Changing NHS England R21 criteria for prenatal exome sequencing

Impact: Public Policy Impact, Health Impact

Description of impact

Based on my recent AJOG paper;
Should we offer prenatal exome sequencing for intrauterine growth restriction or short long bones? A systematic review and meta-analysis Mone, et al. 2022. AJOG. The criteria for NHS England prenatal exome sequencing inclusion has been expanded to include any fetus with short long bones or fetal growth restriction (Severe and early) where placental disease has been outruled

Who is affected

All pregnant women in NHS England and potentially beyond

Narrative

This was presented by Prof Lyn Chitty to the NHS England R21 Workshop
Impact statusCompleted
Impact date03 Oct 2022
Category of impactPublic Policy Impact, Health Impact
Impact levelAdoption

Keywords

  • sequencing

Related content